Products
U-GEMMs

Toolbox of Mice

Find Cre

Reporters

Target Humanized Knockins

Tumor Targets

Immune Checkpoints

Complements

Cytokines

Cytokine Receptors

Metabolic Targets

Viral Infection Receptors

Other Targets

Disease Mice

Spontaneous Tumor

Rare Disease

Infectious Disease

Nervous System Disease

Cardio-metabolic Disease

Autoimmune Disease

Immune-Related Mice

Humanized Drug Targets

Immunodeficient

Cytokine Reporters

Inducible Cell Ablation

Cell-specific Reporters

Popular Strains

Humanized PD-1 Mice

Humanized PD-L1 Mice

NMG Mice

Other Models

Rats

Humanized Drug Targets

Immunodeficient

Diseases

Reporters

Cre-drivers

Standard Strains

Inbred

Outbred

Cells

Reporter-labeled

Primary

Humanized Drug Targets

Wild-type

Others

Supporting Solutions

Colony Management

Cryopreservation and Cryorecovery

Housing and Management

Genotyping Analysis

Breeding Services

Auxiliary Apparatuses

e-BLOT WB Imaging System
Services
Model Customization

Gene Editing Technology

ES Cell Targeting

CRISPR Gene Editing

Transgene

Genetically Engineered Type

Conventional Knockout (KO)

Conditional Knockout (CKO)

KO First

Knock-in (KI)

Point Mutation

Conditional Point Mutation

Humanization

Targeted Conditional Overexpression

Random Transgene

Surgery & Preconditioning

Surgery

Preconditioning

Therapeutic Area

Oncology

Syngeneic Models

GEMM-Derived Allografts

Humanized Mice

CDX Models

PDX Models

Humanized Drug Target IO Mice

Nervous System Disease

Parkinson's Disease Mouse Model

Mouse Model of Lumbocrural Pain

Autoimmune Disease

Psoriasis Mice

EAE Mice

Digestive System Disease

Intestinal Inflammation Model

Experimental Model of Liver Fibrosis

Mouse Model of Liver Regeneration

Mouse Model for Gastrectomy

Metabolic Disease

High Fat Diet Induced Diabetic Mice

Preclinical Services

Non-GLP Toxicology

Pharmacokinetics

Phenotype Analysis

Pharmacology & Pharmacodynamics
Resources & Support
Resources

Literature Library

Model Publications

Health Reports

External Resources

Support

Search for Mice

Search for Publications

Frequently Asked Questions (FAQ)

Applications
About Us
SMOC

Who We are

Credentials

Milestones

Contact Us

Payment Information
Investor Relations

English
Cart 0

hLILRB2-hLILRB3-Tg

Nomenclature

C57BL/6Smoc-Tg(loxp-LILRB2-LILRB3-FRT-PGK-PuropolyA-FRT-lox2272)

Cat. NO.

NM-TG-220136

Strain State

Sperm cryopreservation

Export PDF

Model Description

These transgenic mice harbor loxp-hLILRB2-hLILRB3-FRT-PGK-PuropolyA-FRT-lox2272 expression cassettes.

*Literature published using this strain should indicate: hLILRB2-hLILRB3-Tg mice (Cat. NO. NM-TG-220136) were purchased from Shanghai Model Organisms Center, Inc..

Validation Data

Fig.1 Detection of hLILRB2 and hLILRB3 expression on myeloid cells in blood in Tg(hLILRB2-hLILRB3) mice.

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more

Workshop：Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more

Contact Back to top